Patent · US Active

Imidazo-oxadiazole and imidazo-thiadiazole derivatives

US9932354B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2013
Grant dateApr 3, 2018
Priority date
Expiry dateMay 23, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula (I) used as Amyloid beta lowering agent for the treatment of neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.